OTCMKTS:MEHCQ 23andMe (MEHCQ) Stock Price, News & Analysis $3.50 0.00 (0.00%) As of 10/2/2026 Add Compare Share Share Stock Analysis Stock AnalysisChartNews and TrendsSEC Filings About 23andMe Stock (OTCMKTS:MEHCQ) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get 23andMe alerts:Sign Up Key Stats Today's Range$3.50▼$3.5050-Day Range$3.50▼$3.5052-Week Range$0.47▼$6.21VolumeN/AAverage Volume129,822 shsMarket Capitalization$96.39 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview 23andMe is a consumer genetics company that provides DNA testing and related genetic-information services. Its Personal Genome Service uses saliva samples to generate reports covering ancestry, family relationships, genetic traits, and, where authorized and available, selected health predispositions and carrier status. The company has also offered wellness information and tools for exploring genetic data. Founded in 2006 by Anne Wojcicki, Linda Avey, and Paul Cusenza, 23andMe helped popularize direct-to-consumer genetic testing. The company has served customers in the United States and selected international markets, although available products and reports vary by geography and regulatory requirements. In addition to consumer testing, 23andMe has used voluntarily contributed genetic and health information to support research programs and partnerships. It also previously expanded into telehealth and drug-development activities. Anne Wojcicki was the company’s co-founder and longtime chief executive officer; 23andMe and certain subsidiaries filed for Chapter 11 bankruptcy protection in 2025, after which the company’s ownership and operating structure became subject to bankruptcy proceedings.AI Generated. May Contain Errors. Read More Receive MEHCQ Stock News and Ratings via Email Sign-up to receive the latest news and ratings for 23andMe and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. MEHCQ Stock News HeadlinesCalifornia sues 23andMe over 2023 data breachMay 28, 2026 | reuters.comNew 23andMe Research Institute Study Identifies Genetic Predictors for GLP-1 Weight Loss Efficacy and Side EffectsApril 8, 2026 | globenewswire.comWall Street legend reveals his top AI stock before Oct. 20Marc Chaikin, the 60-year Wall Street veteran behind the Power Gauge rating system, has flagged a new AI stock ahead of October 20. His system has spotted at least seven of the top 10 performers every year since 2016, including all ten in the 2022 bear market and every member of the Magnificent Seven before their run higher. Now Chaikin's Power Gauge is turning bullish on an under-the-radar company tied to next-generation AI data centers built under Executive Order 14363, technology he says uses 99 percent less electricity and space while offering far greater computing power. | Chaikin Analytics (Ad)23andMe Introduces Reconstructed Ancestors a First-of-Its-Kind DNA Discovery ToolMarch 13, 2026 | globenewswire.com3 Biotech Stocks Wall Street Analysts Predict Will More Than DoubleNovember 20, 2025 | msn.com23andMe Research Institute Helps Reconnect African Diaspora to Their Roots with Release of 250+ High-Resolution African Genetic GroupsNovember 20, 2025 | globenewswire.com23andMe Research Institute Names Brad Margus and Stephen Quake, D.Phil., to Board of DirectorsOctober 24, 2025 | globenewswire.com23andMe Holding Submits August 2025 Operating ReportOctober 6, 2025 | msn.comSee More Headlines MEHCQ Stock Analysis - Frequently Asked Questions How have MEHCQ shares performed this year? 23andMe's stock was trading at $3.50 at the beginning of 2026. Since then, MEHCQ shares have increased by 0.0% and is now trading at $3.50. How do I buy shares of 23andMe? Shares of MEHCQ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Today10/03/2026Fiscal Year End3/31/2027Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorHealthcare Industry Pharmaceuticals Sub-IndustryPharmaceuticals Current SymbolOTCMKTS:MEHCQ CIK1804591 Webwww.23andme.com Phone650-938-6300FaxN/AEmployeesN/AYear Founded2006Profitability EPS (Trailing Twelve Months)($4.21) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$280.89 million Net Margins-130.25% Pretax Margin-116.70% Return on Equity-827.24% Return on Assets-87.31% Debt Debt-to-Equity RatioN/A Current Ratio0.81 Quick Ratio0.69 Sales & Book Value Annual Sales$189.90 million Price / Sales0.51 Cash FlowN/A Price / Cash FlowN/A Book Value($0.97) per share Price / Book-3.61Miscellaneous Outstanding Shares27,541,000Free Float20,292,000Market Cap$96.39 million OptionableN/A Beta2.12 7 Stocks to Buy Before the Robotics RevolutionRobotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.Get This Free Report This page (OTCMKTS:MEHCQ) was last updated on 10/4/2026 by MarketBeat.com Staff. From Our PartnersElon Warns "America Will Go Bankrupt". Trump's Plan Inside.National debt just crossed 40 trillion dollars, and Elon Musk says America is 1,000% going to go bankrupt with...American Hartford Gold | SponsoredThe case for $20,000 gold before year endPresident Trump reposted a warning from precious metals expert Jim Rickards, tying the November midterms and A...Stansberry Research | SponsoredSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...Altimetry | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredElon Musk’s One Stock Retirement PlanJeff Brown picked Nvidia in 2016, before it surged 37,000 percent. Now he's tracking a small AI company he say...Brownstone Research | SponsoredHow options let you do more with less capitalWould you rather spend $5,000 buying 100 shares of a $50 stock, or control those same 100 shares for a fractio...Base Camp Trading | SponsoredThey didn't warn anyone in 1971. This time someone is warning you.On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredNew Chip takes minutes, not daysGeorge Gilder believes today's AI data centers could become tomorrow's typewriters - replaced by a single wafe...Eagle Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding 23andMe Holding Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share 23andMe With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
